266 related articles for article (PubMed ID: 35359844)
1. Proton Pump Inhibitors and Cancer: Current State of Play.
Bridoux M; Simon N; Turpin A
Front Pharmacol; 2022; 13():798272. PubMed ID: 35359844
[No Abstract] [Full Text] [Related]
2. Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT).
Kim SY; Lee JS; Kang J; Morita S; Park YS; Sakamoto J; Muro K; Xu RH; Kim TW
Oncologist; 2021 Jun; 26(6):e954-e962. PubMed ID: 33644953
[TBL] [Abstract][Full Text] [Related]
3. Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.
Chu MP; Hecht JR; Slamon D; Wainberg ZA; Bang YJ; Hoff PM; Sobrero A; Qin S; Afenjar K; Houe V; King K; Koski S; Mulder K; Hiller JP; Scarfe A; Spratlin J; Huang YJ; Khan-Wasti S; Chua N; Sawyer MB
JAMA Oncol; 2017 Jun; 3(6):767-773. PubMed ID: 27737436
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions due to drug-drug interactions with proton pump inhibitors: assessment of systematic reviews with AMSTAR method.
Yucel E; Sancar M; Yucel A; Okuyan B
Expert Opin Drug Saf; 2016; 15(2):223-36. PubMed ID: 26635063
[TBL] [Abstract][Full Text] [Related]
5. Drug-drug interaction profiles of proton pump inhibitors.
Ogawa R; Echizen H
Clin Pharmacokinet; 2010 Aug; 49(8):509-33. PubMed ID: 20608754
[TBL] [Abstract][Full Text] [Related]
6. Drug-drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure.
Raoul JL; Moreau-Bachelard C; Gilabert M; Edeline J; Frénel JS
ESMO Open; 2023 Feb; 8(1):100880. PubMed ID: 36764092
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper.
Raoul JL; Edeline J; Simmet V; Moreau-Bachelard C; Gilabert M; Frénel JS
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267464
[TBL] [Abstract][Full Text] [Related]
8. Controversial link between proton pump inhibitors and anticancer agents: review of the literature.
Meriggi F
Tumori; 2022 Jun; 108(3):204-212. PubMed ID: 34159850
[TBL] [Abstract][Full Text] [Related]
9. Association and Mechanisms of Proton Pump Inhibitors Use with Type-2 Diabetes Mellitus Incidence in Adults: A Systemic Review and Metaanalysis.
Chenchula S; Sharma P; Ghanta MK; Amerneni KC; Rajakarunakaran P; Saggurthi P; Chandra MB; Gupta R; Chavan M
Curr Diabetes Rev; 2024 Jan; ():. PubMed ID: 38243950
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor prescribing patterns and utilization: A retrospective chart review analysis.
Algabbani AM; Alangari AS
Saudi Pharm J; 2023 Dec; 31(12):101841. PubMed ID: 37961073
[TBL] [Abstract][Full Text] [Related]
11. Interaction Between Low-Dose Methotrexate and Nonsteroidal Anti-inflammatory Drugs, Penicillins, and Proton Pump Inhibitors.
Hall JJ; Bolina M; Chatterley T; Jamali F
Ann Pharmacother; 2017 Feb; 51(2):163-178. PubMed ID: 27701081
[TBL] [Abstract][Full Text] [Related]
12. Proton Pump Inhibitor Use and Adverse Effects in South Atlantic Hospitals.
D'Angelo N; Sigarchy R; Esswein A; Asrar S
HCA Healthc J Med; 2023; 4(5):353-358. PubMed ID: 37969849
[TBL] [Abstract][Full Text] [Related]
13. Adverse Events of Proton Pump Inhibitors: Potential Mechanisms.
Corsonello A; Lattanzio F; Bustacchini S; Garasto S; Cozza A; Schepisi R; Lenci F; Luciani F; Maggio MG; Ticinesi A; Butto V; Tagliaferri S; Corica F
Curr Drug Metab; 2018; 19(2):142-154. PubMed ID: 29219052
[TBL] [Abstract][Full Text] [Related]
14. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
Dharmarajan TS
J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
[TBL] [Abstract][Full Text] [Related]
16. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer.
Wong GG; Ha V; Chu MP; Dersch-Mills D; Ghosh S; Chambers CR; Sawyer MB
Clin Colorectal Cancer; 2019 Mar; 18(1):72-79. PubMed ID: 30551953
[TBL] [Abstract][Full Text] [Related]
17. Perils and pitfalls of long-term effects of proton pump inhibitors.
Wilhelm SM; Rjater RG; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
[TBL] [Abstract][Full Text] [Related]
18. Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study.
Wang H; Shi H; Wang Y; Wang N; Li Y; Yang Q; Li Y; Liu C; Zan Y; Feng S; Xie J
Front Pharmacol; 2022; 13():808848. PubMed ID: 35177990
[No Abstract] [Full Text] [Related]
19. Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis.
Boonpheng B; Thongprayoon C; Bathini T; Sharma K; Mao MA; Cheungpasitporn W
World J Transplant; 2019 Jun; 9(2):35-47. PubMed ID: 31363460
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors: Review of Emerging Concerns.
Nehra AK; Alexander JA; Loftus CG; Nehra V
Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
